Literature DB >> 32052173

Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence.

Mariken Dinnissen1, Andrea Dietrich2, Judith H van der Molen2, Anne M Verhallen2,3, Ynske Buiteveld2, Suzanne Jongejan2, Pieter W Troost4, Jan K Buitelaar5,6, Pieter J Hoekstra2, Barbara J van den Hoofdakker2,7.   

Abstract

Antipsychotics are often prescribed to children and adolescents, mostly off-label. We aimed to assess adherence to recommendations of guidelines for antipsychotic prescription. We reviewed 436 medical records from 155 clinicians from 26 clinics within three Dutch child and adolescent psychiatry organizations (n = 398 outpatient, n = 38 inpatient care). We assessed target symptoms, diagnostic process, prior and concomitant treatment, and consideration of contra-indications. Multiple logistic regression assessed the role of age, sex, and psychiatric diagnosis on adherence to three main recommendations: to (1) prescribe antipsychotics only after other treatments proved insufficient, (2) always combine antipsychotics with psychosocial interventions, and (3) not prescribe multiple antipsychotics simultaneously. Most patients received off-label antipsychotics. Main target symptoms were inattention/hyperactivity (25%), aggression (24%), and other disruptive behaviors (41%). Most patients underwent diagnostic evaluation before the first prescription; however, screening of contra-indications was low (0.2-19%). About 84% had previously received psychosocial treatment and 48% other psychoactive medication, but 9% had not received any treatment. Notably, only 37% continuously received concomitant psychosocial treatment. Simultaneous use of multiple antipsychotics occurred in 3.2%. Younger children were at higher risk of non-adherence to guideline recommendations regarding prior and concomitant treatment, children with autism spectrum disorder or attention-deficit/hyperactivity disorder more likely not to receive concomitant psychosocial treatment. Sex did not significantly affect adherence. Our findings implicate insufficient adherence to important recommendations regarding antipsychotic use in children and adolescents. Especially younger children are at higher risk of receiving suboptimal care. There is an urgency to consistently offer psychosocial interventions during antipsychotic treatment.

Entities:  

Keywords:  Adolescents; Antipsychotics; Children; Guidelines; Prescription

Year:  2020        PMID: 32052173     DOI: 10.1007/s00787-020-01488-6

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  6 in total

1.  Minding the gap between clinical guidelines and real-life clinical work.

Authors:  Livia Balan-Moshe; Doron Gothelf
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-05       Impact factor: 4.785

2.  Updated European guidelines for Tourette syndrome: and now use them!

Authors:  Pieter J Hoekstra; Veit Roessner
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-03       Impact factor: 4.785

3.  First do no harm: use off-label antipsychotic medication in children and adolescents with great caution.

Authors:  Pieter J Hoekstra; Andrea Dietrich
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-01       Impact factor: 4.785

4.  Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents: A Patient Record Review.

Authors:  Mariken Dinnissen; Andrea Dietrich; Judith H van der Molen; Anne M Verhallen; Ynske Buiteveld; Suzanne Jongejan; Pieter W Troost; Jan K Buitelaar; Barbara J van den Hoofdakker; Pieter J Hoekstra
Journal:  J Clin Psychopharmacol       Date:  2021 Jan/Feb 01       Impact factor: 3.118

5.  Association of Treatment With Antipsychotics, Antidepressants, or Both With Movement Disorders and Seizures Among Children and Adolescents With Depression in Korea.

Authors:  Soo Min Jeon; Hae-Young Park; Susan Park; Un Sun Chung; Jin-Won Kwon
Journal:  JAMA Netw Open       Date:  2022-04-01

6.  Gender differences in the use of atypical antipsychotics in early-onset schizophrenia: a nationwide population-based study in Brazil.

Authors:  Izabela Fulone; Marcus Tolentino Silva; Luciane Cruz Lopes
Journal:  BMC Psychiatry       Date:  2021-06-29       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.